Fibrocell Provides Final Data To Resolve FDA Concerns On Its Autologous Stem Cell Therapy For Facial Wrinkles
This article was originally published in The Pink Sheet Daily
Executive Summary
The biotech hopes next to advance its technology into treatment of acne scarring; the laViv PDUFA date is June 22.